Abstract
The Cobra Perilaryngeal Airway™ (Engineered Medical Systems, Indianapolis, IN) is a new supraglottic airway designed for spontaneous and controlled ventilation. It is not yet commercially available in the UK. Our aim was to evaluate the performance of the Cobra Perilaryngeal Airway™ in a cohort study and in a randomised, controlled, crossover comparison study with the Classic Laryngeal Mask Airway™. After studying 29 patients, both studies were suspended and later stopped after two cases of significant pulmonary aspiration had occurred in patients whilst using the Cobra Perilaryngeal Airway™. These cases raised concern about both the design and the safety of the Cobra Perilaryngeal Airway™, particularly during controlled ventilation. We suggest that the Cobra Perilaryngeal Airway™ should not be marketed for controlled ventilation until more safety data are available. 2005 Blackwell Publishing Ltd.
Cite
CITATION STYLE
Cook, T. M., & Lowe, J. M. (2005). An evaluation of the Cobra Perilaryngeal AirwayTM: Study halted after two cases of pulmonary aspiration. Anaesthesia, 60(8), 791–796. https://doi.org/10.1111/j.1365-2044.2005.04261.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.